Activity guided fractionations led to the isolation of two antitumor compounds 5a,8a-epidioxy-24(R )-methylcholesta-6,22-dien-3b-D-glucopyranoside and 5,6-epoxy-24(R )-methylcholesta-7,22-dien-3b-ol from the methanol extract of Cordyceps sinensis. Two previously known compounds, ergosteryl-3-O-b-D-glucopyranoside and 22-dihydroergosteryl-3-O-b-D-glucopyranoside were also isolated. The structures of hitherto unknown sterols were established by 1D and 2D NMR spectroscopic techniques with the former synthesized in order to con®rm the identity of the sugar moiety by chemical correlation. The glycosylated form of ergosterol peroxide was found to be a greater inhibitor to the proliferation of K562, Jurkat, WM-1341, HL-60 and RPMI-8226 tumor cell lines by 10 to 40% at 10 mg/ml than its previously identi®ed aglycone, 5a,8a-epidioxy-24(R )-methylcholesta-6,22-dien3b-ol. #
Introduction
Cordyceps sinensis (Berk.) Sacc.
(family Clavicipitaceae) has long been used in Chinese medicine to treat numerous illnesses, promote longevity, relieve exhaustion and increase athletic prowess (Pegler, Yao & Li, 1994; Steinkraus & Whit®eld, 1994; Jones, 1993; Tsunoo, Taketomo, Tsuboi, Kamijio, Nemoto, Sasaki, Uchida, Yamashita, Kinjo & Haung, 1995) . The medicinal preparation from the fruiting bodies of C. sinensis is named dong-chong-xia-cao which translates as winter worm and summer grass. C. sinensis infects the larvae of the sphinx moth, Hepialus armoricanus, found only in the highlands of the Himalayan region, and the larva hibernates underground through the winter. The fungus kills the infected host and grows throughout the cadaver, and in the summer, a rod-like stroma of the fungus grows out from the mummi®ed shell of the dead host. Cordyceps species are generally known as the`caterpillar fungus' due to this characteristic parasitism of the living larvae of insects (Pegler, Yao & Li, 1994; Steinkraus & Whit®eld, 1994; Jones, 1993) .
A number of bioactive constituents from Cordyceps species have been reported. These include: cordycepin (Cunningham, Herchinson, Manson & Spring, 1951; Kredich & Guarino, 1960) and other antibacterial and antitumor adenosine derivatives (Furuya, Hirotani & Matsuzawa, 1983) , ophicordin, an antifungal agent (Kneifel, Srinivasan & Maiti, 1957) , a polysaccharide shown to have antitumor activity (Miyazaki, Oikawa & Yamada, 1977; Yamada et al., 1984; Ohmori, Tamura, Tsuru & Nomoto, 1986) , an immunopotentiating galactomannan, and L-tryptophan (Zhang, Zhang, Zhu & Chen, 1991) . A recent report indicated that the fruiting body of C. sinensis contained growth inhibitors against tumor cells (K562, Vero, Wish, Calu-1 and Raji) other than cordycepin and polysaccharides (Kuo, Ching-Yuang Lin, Wei-Jern Tsai, Wu, Phytochemistry 51 (1999) 891±898 0031-9422/99/$ -see front matter # 1999 Elsevier Science Ltd. All rights reserved. PII: S 0 0 3 1 -9 4 2 2 ( 9 9 ) 0 0 1 2 8 -4
Chen & Shiao, 1994). We report herein the isolation and identi®cation of two antitumor compounds from the mycelia of C. sinensis. Activity guided chemical fractionations of the methanol extract of C. sinensis, led to the isolation of a steroidal glycoside 5a,8a-epidioxy-24(R )-methylcholesta-6,22-dien-3b-D-glucopyranoside (1a) and 5a,6a-epoxy-24(R )-methylcholesta-7,22-dien-3b-ol (2).
Two previously identi®ed compounds, ergosteryl-3-O-b-D-glucopyranoside (3) and 22,23-dihydroergosteryl-3-O-b-D-glucopyranoside (4) were also isolated during the fractionation of the methanol extract (Shiao, Lin, Lien, Tzean & Lee, 1989) . These ergosterol derivatives were not active against the tumor cell lines used in this study.
Results and discussion
Compounds 3 and 4 were identi®ed by 1 H NMR spectroscopy as ergosteryl-3-O-b-D-glucopyranoside (3) and 22,23-dihydroergosteryl-3-O-b-D-glucopyranoside (4) previously isolated from the fruiting body of C. sinensis (Shiao et al., 1989 indicates that the attachment of the sugar moiety at C3 is in the b-con®guration (Shiao et al., 1989; Ahmed, Ahmed & Malik, 1992; Wasylyk, Martin, Weinheimer & Alam, 1989) , similar to that of the ergosteryl-3-O-b-D-glucopyranoside (3) and 22,23-dihydroergosteryl-3-O-b-D-glucopyranoside (4) (Shiao et al., 1989) . The observation of the two doublets at d 6.39 (1H, d, J=8.5 Hz) and 6.13 (1H, d, J=8.5 Hz), approximately 1 ppm down®eld of the H6 and H7 ole®nic protons in 3 and 4, suggested that the aglycone of 1a is 5a,8a-epidioxy-24(R )-methylcholesta-6,22-diene3b-ol (1b). The close comparison of the 13 C data of 1a with 1b listed in Table 1 agrees with this proposal.
The identity of the sugar moiety in 1a was not con-clusive from the spectroscopic data. However comparison of the 1 H and 13 C NMR spectra of 1a with the spectra of the glucopyranosides 3 and 4 suggests that 1a is also a glucopyranoside. The synthesis of 5a,8a-epidioxy-24(R )-methylcholesta-6,22-dien-3b-D-glucopyranoside (1a) from ergosterol (6) was carried out as shown in Scheme 1. Deacetylation of 5 (CernyÂ , Pouzar, Drasar, Budesinsky & Havel, 1984) followed by a Diels±Alder addition of singlet O 2 ( 1 D g ) to the diene in ergosteryl-3-O-b-D-glucopyranoside (3) (Gunatilaka, Gopichand, Schmitz & Djerassi, 1981) aorded 5a,8a-epidioxy-24(R )-methylcholesta-6,22-dien-3b-D-glucopyranoside (1a). Comparison of the 1 H and 13 C NMR of the synthesized molecule both con®rmed the proposed identity of the sugar moiety and the stereochemistry of the 5a,8a-epideoxy functionality in the isolated compound 1a.
5a,8a-Epidioxy-24(R )-methylcholesta-6,22-dien-3b-D-glucopyranoside has previously been isolated from a variety of fungi (including C. sinensis ) (Xiao, Liu & Tu, 1983; Takaishi, Adachi, Murakami, Ohashi, Nakano & Tomimatsu, 1992; Tsantrizos, Folkins, Britten, Harpp, Ogilvie, 1992) , lichens (Hirayama, Fujikawa, Yosioka & Kitagawa, 1975; Gonzalez, Barrera, Perez & Padron, 1992) , and marine organisms (Gunatilaka et al., 1981; Guyot & Durgeat, 1981) and has been shown to have both antitumor (Kahlos, Kangas & Hiltunen, 1989; Kahlos, Hiltunen & Kangas, 1989; Matsueda, Shimoyama, Imaizumi & Tsushima, 1982; Cheng, Nagano, Bang, Ourrison, Beck, 1977) and anti-in¯ammatory (Yasukawa et al., 1994 (Yasukawa et al., , 1996 activity. Formation of 1b was shown to be endogenous in fungi and not an artifact of the isolation procedure (Nes, Xu & Haddon, 1989) . Scheme 1. Synthesis of 5a,8a-epidioxy-24(R )-methylcholesta-6,22-dien-3b-D-glucopyranoside (1a); (i) 2,3,4,6-tetra-O-acetyl-a-D-glucosyltrichloroacetimidate, CH 2 Cl 2 , 4 A Ê mol. sieves, BF 3 .Et 2 O; ii) MeOH, Et 3 N, H 2 O (40:6:1) (Gunatilaka, Gopichand, Schmitz & Djerassi, 1981) ; (iii) O 2 , eosin, EtOH, (500 W) hv. .3347). The additional oxygen in the molecular formula of 2 in comparison to the molecular formula of ergosterol (6) (C 28 H 44 O) and the observation in the 1 H NMR of a signal at 3.50 ppm combined with the loss of an ole®nic signal indicates that one of the 5,7-diene ole®ns in 6 has been oxidized to the epoxide. The observation of a correlation in the COSY between the trisubstituted epoxy methine signal at 3.50 ppm and the ole®n methine signal at 5.20 ppm is in agreement with this proposal. The observation of cross-peaks in the HMBC between the signal at 5.20 ppm with the 13 C signals corresponding to C5, C9 and C14 and the cross peaks for the signal at 3.50 ppm with the 13 C signals corresponding to C5, C7, C8 and C10 indicate the epoxide is in the 5,6 position. The down®eld chemical shift of the 3b-hydroxy methine at 3.90 ppm is consistent with the a stereochemistry for the 5, 6-epoxy group (Aiello, Fattorusso, Magno, Mayol & Menna, 1990; Isaacs, Berman & Kashman, 1991; Venkateswarlu, Reddy & Rao, 1996) . 5a, 6a-Epoxy sterols similar to compound 2 are unknown. A small number of 5a, 6a-epoxy sterols have been isolated from marine sponges and corals (Aiello et al., 1990; Isaacs, Berman & Kashman, 1991; Venkateswarlu, Reddy & Rao, 1996; Kobayashi & Kanda, 1991) and have been shown to have cytotoxic activities.
Growth inhibition due to compounds 1a, 1b,and 3 of the malignant cell lines K562 (erythroleukemia), Jurkat (T-lymphoblastic), HL-60 (promyelocytic leukemia), WM1341 (malignant melanoma) and RPMI 8226 (multiple myeloma) from the American Tissue Type Collection (ATCC) Rockville, MD, were studied to compare their antitumor activity. The percent inhibition of the proliferation of these ®ve malignant cells lines determined from 3 H-thymidine incorporation assays are shown in Fig. 1(a±d) for 200, 100 and 10 mg/ml concentrations of compounds 3, 1b, and 1a.
Compound 3 which does not contain the 5, 8-epoxy functionality showed little to no signi®cant inhibition of proliferation of the tumor cells. Some inhibition of Jurkat and RPMI 8226 was detected at 200 mg/ml, the highest concentration in this study. As clearly shown on the graphs, at the lower concentration, the glycoside 1a was found to inhibit proliferation of all ®ve malignant cell lines to a greater extent (10±40%) than the aglycone 1b as a control.
Experimental

General
IR spectra were acquired with a Bomen FT-IR Michaelson-100 spectrophotometer. The spectra were obtained either in CHCl 3 solution using a 0.2 mm thick NaCl cell, or as a solid in KBr, and processed using the Bomen Spectra Calc program. LRMS and HRMS were obtained on a Kratos-AEI model MS-50 spectrometer. All spectra were obtained at an ionization energy of 70 eV.
1 H NMR spectra were obtained on a Bruker WH-400 spectrometer.
13 C and APT were obtained on a Bruker AC-200 spectrometer. HMBC, and HMQC spectra were obtained on a Bruker AMX-500 spectrometer. Silica gel (Art 60, 230±400 mesh) for column chromatography (CC) and silica gel (Kieselgel 60 F 254 ) coated on aluminum plates for thin layer chromatography were supplied by Merck.
Fungal material
The mycelial sample of C. sinensis was obtained from North American Reishi, Box 1780, Gibsons, British Columbia, Canada, V0N 1V0.
Malignant cell inhibition studies
3 H-Thymidine incorporation assays were carried out to determine inhibitory eects. K562 (erythroleukemia), Jurkat (T-lymphoblastic), HL-60 (promyelocytic leukemia), WM1341 (malignant melanoma) and RPMI 8226 (multiple myeloma) malignant cell lines were obtained from the American Tissue Type Collection (ATCC), Rockville, MD. The cell lines were maintained in a medium consisting of RPMI 1640/FCS 10% at 378C in an atmosphere of 5% CO 2 . Malignant cell lines,10 6 cells/ml in 96-well round bottom plates (Costar), were cultured with various concentrations of C. sinensis extracts in a 5% CO 2 -air humidi®ed atmosphere at 378C. After 16 h of coculture, 3 H-thymidine (1 MCi/well, Dupont, Montreal) was added to each well.
3 H-Thymidine uptake was measured after 6 hours of incubation using a scintillation counter. The inhibitory eect of each extract on tumor cell proliferation was calculated using Eq. 1.
Inhibition percent %
Control group cpm À Experimental group cpm Control group cpm Â 100 
Activity guided fractionation of fungal material
The dry mycelium of C. sinensis (150 g) was extracted with MeOH three times (500 ml Â 3). The MeOH extracts were combined and the solvent was removed under reduced pressure. The crude MeOH extract was found to inhibit K562 proliferation by 36% at 500 mg/ml, in the 3 H-thymidine incorporation assay. The residue was then redissolved in MeOH/H 2 O (1:1) and washed with hexanes. Methanol was distilled from the aqueous layer under reduced pressure. The remaining aqueous layer was extracted with EtOAc. Concentration of the combined EtOAc extracts under reduced pressure provided 1.57 g of a brown oil (B1).
This residue was chromatographed on a silica gel-¯ash column (230±400 mesh, 50 Â 8.0 cm). The elution was started with CHCl 3 and the polarity of solvents was increased stepwise in the following sequence: CHCl 3 , CHCl 3 /MeOH (8:2), CHCl 3 /MeOH (5:5), CHCl 3 / MeOH (2:8) and MeOH. Fourteen fractions (FA1± FA14) were collected and dried in vacuo. Only one fraction (FA8) was found have antitumor activity. Fraction FA8 was further chromatographed on a silicagel¯ash-column eluted with CHCl 3 /MeOH (8:2) to aord two fractions FB1 and FB2 having an Rf=6.3 and 5.4, respectively. FB1 was a white solid (38 mg). Recrystallization of FB1 in CHCl 3 aorded 10 mg of 2 as a white powder. Compound 2 was found to have 61% antitumor activity against Jurkat cells and 36.3% activity against K562 cells at 100 mg/ml. Fraction FB2 was found to have 96% activity against Jurkat cells and 77% activity against K562 cancer cells at 100 mg/ ml. FB2 was further separated by silica gel chromatography eluted with Et 2 O:hexanes:MeOH=5:5:1 to aord two fractions FC1 (Rf=6.3) and 3 mg of compound 1a (Rf=5.4) as a white solid. FC1 was further separated by HPLC to give 3 and 4.
3.4.1. 5a a,6a a-Epoxy-24(R )-methylcholesta-7,22-dien-3b bol (2).
IR ( 
Synthesis of 1a from ergosterol (6)
All reactions were carried out under nitrogen atmosphere in¯ame-dried glassware unless otherwise stated.
To a stirring solution of 2,3,4,6-tetra-O-acetyl-a-Dglucosyl trichloroacetimidate (0.172 g, 0.4 mmol) in 10 ml dry CH 2 Cl 2 was added 4 A Ê molecular sieves (1 g) followed by ergosterol (6) (0.2 g, 0.5 mmol) as a solid powder. The solution was cooled to 08C prior to the dropwise addition of BF 3 .Et 2 O (0.4 ml of stock 30 ml in 2.5 ml CH 2 Cl 2 ). Upon the addition of BF 3 .Et 2 O the Table 2 13 C NMR chemical shifts of the isolated compounds from C. sinensis 5a,8a-epidioxy-24(R )-methylcholesta-6,22-dien-3b-D-glucopyranoside (1a), 5a,6a-epoxy-24(R )-methylcholesta-7,22-dien-3b-ol (2), ergosteryl-3-O-b-D-glucopyranoside (3) and for comparison compound 5a,8a-epidioxy-24(R )-methylcholesta-6,22-diene-3b-ol (1b) 17.6, 19.2, 19.6, 19.6, 19.9, 20.5, 20.6, 20.7, 21.0, 22.9, 28.2, 29.7, 33.0, 33.0, 37.1, 37.4, 38.2, 39.0, 40.3, 42.8, 46.1, 54.5, 55.7, 62.0, 68.5, 71.4, 71.7, 72.8, 78.6, 99.5, 116.1, 119.9, 131.9, 135.4, 139.0, 141.6, 169.2, 169.3, 170.3, 170.6 .
To a stirring solution of 5 (0.0564 g, 0.078 mmol) in 20 ml MeOH was added 3 ml Et 3 N and 0.5 ml H 2 O. After stirring for 48 h the solvent was removed under reduced pressure. The residue was applied to a silica gel column, and eluted with 15% MeOH in CHCl 3 (Rf=20.6) to aord a white solid. Recrystallization from MeOH provided 3 (0.0351 g, 0.063 mmol) in 81% yield as small white needles. IR (cm À1 Table 2 .
3.5.3. 5a a,8a a-Epidioxy-24(R )-methylcholesta-6,22-dien3b b-D-glucopyranoside (1a)
To a solution of 3 (0.0211 g, 0.038 mmol) in 20 ml dry EtOH was added 2 drops of a 10% solution of eosin in EtOH. Oxygen was bubbled through the solution. The reaction vessel was then placed in a silver dewa and irradiated with a 500 W tungsten lamp.
Water was circulated into the dewar to maintain room temperature for the reaction. After 3 h the solution was concentrated under reduced pressure, with the resulting residue applied to a silica gel column what we eluted with 15% MeOH in CHCl 3 to aord 1a (0.0138 g, 0.023 mmol) in 62% yield as a white solid. IR, 1 H, 13 C and LRMS were identical to spectra of 1a isolated from the mycelia of C. sinensis.
3.5.4. Synthesis of 5a a,8a a-epidioxy-24(R )-methylcholesta-6,22-dien-3b b-ol (1b) (ergosterol peroxide) from ergosterol (6) Following the same procedure as used for the preparation of 1a from 3, ergosterol (6) 
